233 related articles for article (PubMed ID: 34531021)
1. Side Effect Patterns in a Crossover Trial of Statin, Placebo, and No Treatment.
Howard JP; Wood FA; Finegold JA; Nowbar AN; Thompson DM; Arnold AD; Rajkumar CA; Connolly S; Cegla J; Stride C; Sever P; Norton C; Thom SAM; Shun-Shin MJ; Francis DP
J Am Coll Cardiol; 2021 Sep; 78(12):1210-1222. PubMed ID: 34531021
[TBL] [Abstract][Full Text] [Related]
2. Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase.
Gupta A; Thompson D; Whitehouse A; Collier T; Dahlof B; Poulter N; Collins R; Sever P;
Lancet; 2017 Jun; 389(10088):2473-2481. PubMed ID: 28476288
[TBL] [Abstract][Full Text] [Related]
3. Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials.
Herrett E; Williamson E; Brack K; Beaumont D; Perkins A; Thayne A; Shakur-Still H; Roberts I; Prowse D; Goldacre B; van Staa T; MacDonald TM; Armitage J; Wimborne J; Melrose P; Singh J; Brooks L; Moore M; Hoffman M; Smeeth L;
BMJ; 2021 Feb; 372():n135. PubMed ID: 33627334
[TBL] [Abstract][Full Text] [Related]
4. The effect of statins on muscle symptoms in primary care: the StatinWISE series of 200 N-of-1 RCTs.
Herrett E; Williamson E; Brack K; Perkins A; Thayne A; Shakur-Still H; Roberts I; Prowse D; Beaumont D; Jamal Z; Goldacre B; van Staa T; MacDonald TM; Armitage J; Moore M; Hoffman M; Smeeth L
Health Technol Assess; 2021 Mar; 25(16):1-62. PubMed ID: 33709907
[TBL] [Abstract][Full Text] [Related]
5. Effect of atorvastatin on muscle symptoms in coronary heart disease patients with self-perceived statin muscle side effects: a randomized, double-blinded crossover trial.
Kristiansen O; Vethe NT; Peersen K; Wang Fagerland M; Sverre E; Prunés Jensen E; Lindberg M; Gjertsen E; Gullestad L; Perk J; Dammen T; Bergan S; Husebye E; Otterstad JE; Munkhaugen J
Eur Heart J Cardiovasc Pharmacother; 2021 Nov; 7(6):507-516. PubMed ID: 32609361
[TBL] [Abstract][Full Text] [Related]
6. Study protocol for statin web-based investigation of side effects (StatinWISE): a series of randomised controlled N-of-1 trials comparing atorvastatin and placebo in UK primary care.
Herrett E; Williamson E; Beaumont D; Prowse D; Youssouf N; Brack K; Armitage J; Goldacre B; MacDonald T; Staa TV; Roberts I; Shakur-Still H; Smeeth L
BMJ Open; 2017 Dec; 7(12):e016604. PubMed ID: 29197834
[TBL] [Abstract][Full Text] [Related]
7. SAMSON and the Nocebo Effect: Management of Statin Intolerance.
Krishnamurthy A; Bradley C; Ascunce R; Kim SM
Curr Cardiol Rep; 2022 Sep; 24(9):1101-1108. PubMed ID: 35759168
[TBL] [Abstract][Full Text] [Related]
8. Introducing the 'Drucebo' effect in statin therapy: a systematic review of studies comparing reported rates of statin-associated muscle symptoms, under blinded and open-label conditions.
Penson PE; Mancini GBJ; Toth PP; Martin SS; Watts GF; Sahebkar A; Mikhailidis DP; Banach M;
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1023-1033. PubMed ID: 30311434
[TBL] [Abstract][Full Text] [Related]
9. High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.
Billings FT; Hendricks PA; Schildcrout JS; Shi Y; Petracek MR; Byrne JG; Brown NJ
JAMA; 2016 Mar; 315(9):877-88. PubMed ID: 26906014
[TBL] [Abstract][Full Text] [Related]
10. The nocebo effect in the context of statin intolerance.
Tobert JA; Newman CB
J Clin Lipidol; 2016; 10(4):739-747. PubMed ID: 27578103
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.
Ghati N; Roy A; Bhatnagar S; Bhati S; Bhushan S; Mahendran M; Thakur A; Tiwari P; Dwivedi T; Mani K; Gupta R; Mohan A; Garg R; Saxena A; Guleria R; Deepti S
Trials; 2020 Oct; 21(1):902. PubMed ID: 33126910
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.
Nissen SE; Stroes E; Dent-Acosta RE; Rosenson RS; Lehman SJ; Sattar N; Preiss D; Bruckert E; Ceška R; Lepor N; Ballantyne CM; Gouni-Berthold I; Elliott M; Brennan DM; Wasserman SM; Somaratne R; Scott R; Stein EA;
JAMA; 2016 Apr; 315(15):1580-90. PubMed ID: 27039291
[TBL] [Abstract][Full Text] [Related]
13. Clinical and psychological factors in coronary heart disease patients with statin associated muscle side-effects.
Peersen K; Munkhaugen J; Sverre E; Kristiansen O; Fagerland M; Vethe NT; Perk J; Husebye E; Dammen T
BMC Cardiovasc Disord; 2021 Dec; 21(1):596. PubMed ID: 34915854
[TBL] [Abstract][Full Text] [Related]
14. Why Do I Get Side Effects? Personalized (N-of-1) Trials for Statin Intolerance and the Nocebo Effect.
Howard JP; Wood FA; Francis DP
Harv Data Sci Rev; 2022; 2022():. PubMed ID: 38344133
[TBL] [Abstract][Full Text] [Related]
15. Statin-associated muscle symptoms in coronary patients: design of a randomized study.
Munkhaugen J; Vethe NT; Fagerland MW; Dammen T; Perk J; Gjertsen E; Otterstad JE; Gullestad L; Bergan S; Husebye E
Scand Cardiovasc J; 2019 Jun; 53(3):162-168. PubMed ID: 31030568
[No Abstract] [Full Text] [Related]
16. Examining the Nocebo Effect of Statins Through Statin Adverse Events Reported in the Food and Drug Administration Adverse Event Reporting System.
Moon J; Cohen Sedgh R; Jackevicius CA
Circ Cardiovasc Qual Outcomes; 2021 Jan; 14(1):e007480. PubMed ID: 33161769
[TBL] [Abstract][Full Text] [Related]
17. What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice.
Finegold JA; Manisty CH; Goldacre B; Barron AJ; Francis DP
Eur J Prev Cardiol; 2014 Apr; 21(4):464-74. PubMed ID: 24623264
[TBL] [Abstract][Full Text] [Related]
18. [How to cope with the nocebo effects of statins?].
Lafeber M; Evers AWM; Klok FA
Ned Tijdschr Geneeskd; 2023 Mar; 167():. PubMed ID: 36920298
[TBL] [Abstract][Full Text] [Related]
19. New insights into managing symptoms during statin therapy.
Robinson JG
Prog Cardiovasc Dis; 2019; 62(5):390-394. PubMed ID: 31669768
[TBL] [Abstract][Full Text] [Related]
20. Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial.
Saw J; Brennan DM; Steinhubl SR; Bhatt DL; Mak KH; Fox K; Topol EJ;
J Am Coll Cardiol; 2007 Jul; 50(4):291-5. PubMed ID: 17659194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
